Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of Clinical and Pharmacological Parameters on Faecal Microbiota Transplantation Outcome in Clostridioides difficile Infections: Results of a 5-Year French National Survey.
Benech N, Cassir N, Alric L, Barbut F, Batista R, Bleibtreu A, Briot T, Davido B, Galperine T, Joly AC, Kapel N, Melchior C, Mosca A, Nebbad B, Pigneur B, Schneider SM, Wasiak M, Scanzi J, Sokol H; French Faecal Transplant Group (GFTF). Benech N, et al. Among authors: scanzi j. Aliment Pharmacol Ther. 2025 Jan;61(1):159-167. doi: 10.1111/apt.18330. Epub 2024 Oct 10. Aliment Pharmacol Ther. 2025. PMID: 39387234 Free PMC article.
Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Can Be the Best Therapeutic Option in Severely Immunocompromised Patients Depending on a Case-by-Case Assessment of the Benefit-to-Risk Ratio.
Benech N, Cassir N, Galperine T, Alric L, Scanzi J, Sokol H; French Fecal Transplant Group. Benech N, et al. Among authors: scanzi j. Gastroenterology. 2024 Aug;167(3):627-628. doi: 10.1053/j.gastro.2024.04.022. Epub 2024 Apr 26. Gastroenterology. 2024. PMID: 38679396 No abstract available.
The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey.
Baunwall SMD, Terveer EM, Dahlerup JF, Erikstrup C, Arkkila P, Vehreschild MJ, Ianiro G, Gasbarrini A, Sokol H, Kump PK, Satokari R, De Looze D, Vermeire S, Nakov R, Brezina J, Helms M, Kjeldsen J, Rode AA, Kousgaard SJ, Alric L, Trang-Poisson C, Scanzi J, Link A, Stallmach A, Kupcinskas J, Johnsen PH, Garborg K, Rodríguez ES, Serrander L, Brummer RJ, Galpérine KT, Goldenberg SD, Mullish BH, Williams HR, Iqbal TH, Ponsioen C, Kuijper EJ, Cammarota G, Keller JJ, Hvas CL. Baunwall SMD, et al. Among authors: scanzi j. Lancet Reg Health Eur. 2021 Jul 19;9:100181. doi: 10.1016/j.lanepe.2021.100181. eCollection 2021 Oct. Lancet Reg Health Eur. 2021. PMID: 34693388 Free PMC article.
Early Transmural Response Assessed Using Magnetic Resonance Imaging Could Predict Sustained Clinical Remission and Prevent Bowel Damage in Patients with Crohn's Disease Treated with Anti-Tumour Necrosis Factor Therapy.
Messadeg L, Hordonneau C, Bouguen G, Goutorbe F, Reimund JM, Goutte M, Boucher AL, Scanzi J, Reymond M, Allimant C, Dapoigny M, Pereira B, Bommelaer G, Buisson A. Messadeg L, et al. Among authors: scanzi j. J Crohns Colitis. 2020 Nov 7;14(11):1524-1534. doi: 10.1093/ecco-jcc/jjaa098. J Crohns Colitis. 2020. PMID: 32533769
Assessment of the effectiveness and safety of ethosuximide in the treatment of abdominal pain related to irritable bowel syndrome - IBSET: protocol of a randomised, parallel, controlled, double-blind and multicentre trial.
Kerckhove N, Scanzi J, Pereira B, Ardid D, Dapoigny M. Kerckhove N, et al. Among authors: scanzi j. BMJ Open. 2017 Jul 18;7(7):e015380. doi: 10.1136/bmjopen-2016-015380. BMJ Open. 2017. PMID: 28720615 Free PMC article. Clinical Trial.
19 results